Unknown OBSERVATIONAL NCT01607021

Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus Infection

Pharmacogenomics Study on IL28B Genetic Variants for Prediction of Drug Response in Chinese Children With HCV Infection.

Sponsor: Beijing 302 Hospital

Conditions Chronic Hepatitis C

Updated 7 times since 2017 Last updated: Aug 14, 2015 Started: Apr 30, 2012 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01607021, this observational or N/A phase trial focuses on Chronic Hepatitis C and remains ongoing. Sponsored by Beijing 302 Hospital, it has been updated 7 times since 2012, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 2 earlier versions

Sep 2017 — Apr 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2017 — Sep 2017 [monthly]

Recruiting NA

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing 302 Hospital

Data source: Beijing 302 Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China